Goldman Urology Clinic is fully embarking on the treatment of urinary stones by utilizing the latest artificial intelligence (AI) technology.
Goldman Urology Clinic recently introduced and commenced operation of 'UROSTONE', a next-generation extracorporeal shock wave lithotripter that incorporates AI technology. This equipment is a urinary stone treatment device equipped with both an AI breathing trigger system and an AI auto-focusing function, which are domestically patent-registered technologies. It is highly regarded for significantly enhancing both precision and efficiency.
Conventional extracorporeal shock wave lithotripters exhibited a limitation where, if the position of the stone subtly shifted due to changes in the patient's breathing, the shock wave impact point would deviate, leading to a decrease in lithotripsy efficiency. In contrast, UROSTONE is equipped with a respiration-linked targeting system where AI analyzes the patient's breathing patterns in real-time and tracks even the subtle movements of the stone, automatically readjusting the shock waves. Through this, the shock waves can continuously strike the center of the stone, significantly improving lithotripsy efficiency and shortening the treatment time.
Furthermore, it is equipped with the nation's only auto-focusing function, which is based on AI image recognition technology. Through this, it autonomously analyzes and adjusts the stone's position and focus, thereby maximizing treatment accuracy.
A representative from Goldman Urology Clinic stated, "Because AI simultaneously detects the patient's breathing and the stone's movement, automatically adjusting the optimal shock waves, more precise and safer lithotripsy is possible. We expect high patient satisfaction as treatment time is reduced, and the burden of pain and re-treatment is decreased."
Reporter Kim Eun-ji